- Home
- MRK vs PANW Comparison
MRK vs PANW Comparison
Compare MRK & PANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | PANW |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | United States | United States |
| Employees | 75000 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.2B | 234.5B |
| IPO Year | 1994 | 2012 |
Fundamental Metrics
Financial Performance| Metric | MRK | PANW |
|---|---|---|
| Price | $119.25 | $289.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 39 |
| Target Price | $125.59 | ★ $216.28 |
| AVG Volume (30 Days) | ★ 8.6M | 8.3M |
| Earning Date | 04-30-2026 | 05-19-2026 |
| Dividend Yield | ★ 3.06% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $65,011,000,000.00 | $2,273,100,000.00 |
| Revenue This Year | $3.61 | $24.93 |
| Revenue Next Year | $5.41 | $19.97 |
| P/E Ratio | ★ N/A | $362.53 |
| Revenue Growth | 1.31 | ★ 29.04 |
| 52 Week Low | $76.66 | $139.57 |
| 52 Week High | $125.14 | $302.95 |
Technical Indicators
Market Signals| Indicator | MRK | PANW |
|---|---|---|
| Relative Strength Index (RSI) | 55.78 | 67.09 |
| Support Level | $112.96 | $179.81 |
| Resistance Level | $123.93 | $302.95 |
| Average True Range (ATR) | 2.97 | 11.72 |
| MACD | -0.28 | -1.67 |
| Stochastic Oscillator | 64.09 | 86.21 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About PANW Palo Alto Networks Inc.
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three-fourths of the Global 2000.